Pharmacy and Pharmaceutical Sciences Commons^™

Sharksrx Newsletter Fall 2026, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Pacific Rxtracts - September 2026, Pacific Rxtracts

Pacific RxTracts

Articles

• Efficacy of Daraxonrasib Versus Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (Breaking News)
• A Multi-Drug, All-Age Unified PopPK Model for Aminoglycoside Dosing (General News)
• Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence (Cardiology)
• Low-Dose Hydrocortisone and Cognition in Women With HIV (Endocrine)
• Rethinking Pediatric Propofol Limits in the Absence of PRIS (Pediatrics)
• Eptinezumab in Chronic Migraine and Medication Overuse Headache: The RESOLUTION Trial (Neuropsychology)
• Ropeginterferon alfa-2b-njft Treatment in Essential Thrombocythemia: Mutation-Stratified Outcomes from EXCEED-ET (Oncology)
• Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes (Infectious Disease)
• Conclusive Evidence in Support of Amoxicillin …

Pacific Rxtracts - August 2026, Pacific Rxtracts

Pacific RxTracts

• Articles:
• FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
• Bemotrizinol: First FDA-Approved Sunscreen Ingredient in 20 Years
• Effects of Mavacamten in Hypertrophic Cardiomyopathy
• Small Increase in Bleeding Risk With Immediate Intensive Statin Therapy and Dual Antiplatelet Therapy in Mild Ischemic Stroke
• Retatrutide for Type 2 Diabetes: The TRANSCEND-T2D-1 Phase 3 Trial
• Reimagining Insulin Therapy: Clinical Impact of CagriSema in REIMAGINE-3
• FDA Approval of Veligrotug-vvze Establishes a New IV Biologic Option for TED
• Novel Oral GLP-1 Receptor Agonist HRS-7535 Shows Promising Results in Type 2 Diabetes
• FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
• Pockets of …

Visible Light Kinetics Of N-Heterocyclic Carbenes As Additives For Native Chemical Ligation, Hannah M. Werle, Kaitlyn S. Marley, John P. Morgan

SURF Posters 2026

Spectroscopic data have been obtained demonstrating that N-heterocyclic carbenes are effective catalysts for linking shorter peptides to form longer ones, a reaction known as “native chemical ligation” (NCL).  This reaction is key to the preparation of GLP-1 agonists, such as Zepbound®, Ozempic®, and Wegovy®, which are currently undergoing an explosion in popularity due to their treatment of diabetes, obesity, and cardiac issues.  To assess which catalysts are faster, the kinetics model developed by Raines et al., involving the reaction of N-acetylphenylalanine p-nitrophenylthioester and L-cysteine, is being utilized. This published model allows for easy monitoring of the rate of reaction for …

Pacific Rxtracts - July 2026, Pacific Rxtracts

Pacific RxTracts

Articles:

• Tribute: In Memory of Evan Le
• Redefining Influenza Prevention: Phase 3 Trial of an mRNA Influenza Vaccine
• Risk of Non-Vitamin K Anticoagulants in Atrial Fibrillation
• Oral Semaglutide and Cardiovascular Risk: Expanding Its Role in High-Risk Patients
• Baxdrostat for Resistant Hypertension: The Bax24 Phase 3 Trial
• SGLT2 Inhibitors Shown to Normalize Blood Pressure in Patients with Type 2 Diabetes
• Brolucizumab: A New Vision for Treating Proliferative Diabetic Retinopathy
• Mavacamten Comes of Age: FDA Expands Treatment Options for Adolescent Hypertrophic Cardiomyopathy
• Children and Adolescent CKD Management: New Evidence Supports RAAS Inhibitors as First-Line Therapy
• Comparing Survival Outcomes of CDK4/6 Inhibitors plus …

Pharmed. System Manual: Hololens Application, Eden Woldeselassie

Systems Manuals - 2026

This document provides the full life cycle of PharmEd HoloLens. PharmEd stands for Pharmacy Education. The overall document will go through the complete system manual by going over requirements, followed by design, how to install the application, how to upload the application to Microsoft store, troubleshooting and source code. The first section will explain the background, the existing problems and why the need to develop PharmEd.  Here techniques of requirement gathering and some statistics will elaborated. The following section discusses about functional requirements. The requirement section includes subtopics: functional and nonfunctional requirements for both -programmer and end user- and the …

Sharksrx Newsletter Summer 2026, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Evaluation Of The Impact Of Pharmacist-Led Toc On Patient Care Outcomes, Taabris Jaamal, Hana Breeland, Thanh Nguyen, Barbara Branneman, Jack Huber, Hung Phan

All Poster Presentations

No abstract provided.

The Impact On Nurses' Knowledge And Confidence Of Simulation With Chimeric Antigen Receptor T-Cell Infusion, Rachael Crickman, Shannon Williams, Heather Bissmeyer, Frances Chu, Cara Gallegos

All Poster Presentations

No abstract provided.

Evaluating Low Molecular Weight Heparin For Venous Thromboembolism Treatment In Extreme Body Weights, Natalie Tran, Brittanii Prahl, Jordan Amaro, Barbara Branneman, Jack Huber

All Poster Presentations

No abstract provided.

Euglycemic Diabetic Ketoacidosis: Institutional Review And Protocol Development, Lim Kang, Jordan Amaro, Brittanii Prahl, Jack Huber

All Poster Presentations

No abstract provided.

Comparable Endogenous Immune Reconstitution, Car-T Expansion, And Cytokine Profiles With Bendamustine Versus Fludarabine/Cyclophosphamide Lymphodepletion, Matthew Schwede, Sarah Hawley, Zachary Reitz, Faith Kierney, Neil Bailey, Tenzin Tsomo, Laiken Lopez, Terry Gilbertson, Christopher A Carney, Doug Kieper, Kelly Paulson, Krish Patel

All Poster Presentations

No abstract provided.

Beyond Ce Credit: A Retrospective Analysis Of Cme And Cpe Impact In A Health System, Diem Pham, Michelle Eng, Brandon Wu

All Poster Presentations

No abstract provided.

Assessment Of Patients With Newly Scheduled Opioids And Inappropriate Bowel Regimen, Melody Kazemini, Ryan Dow, Brittanii Prahl, Barbara Branneman, Jack Huber

All Poster Presentations

No abstract provided.

Thromboembolic Outcomes In Patients Receiving Doacs With Concomitant Antiseizure Medication, Hermela Gebregiogris, Brittanii Prahl, Michael Schirmer, Barbara Branneman, Jack Huber, Lam Vo

All Poster Presentations

No abstract provided.

Comparative Analysis Of Emergency Department Pain Medications Given For Treatment Of Sickle Cell Pain Crisis, Christo Mitchell, Kristian Campbell, Brittanii Prahl, Jack Huber

All Poster Presentations

No abstract provided.

Pacific Rxtracts - June 2026, Pacific Rxtracts

Pacific RxTracts

Articles:

• FDA Approves First Non-Antipsychotic Drug for Patients with Alzheimer’s Disease Agitation
• FDA Approves Sparsentan for Focal Segmental Glomerulosclerosis
• Lunsotogene Rings in a New Era of Gene Therapy for Hearing Loss
• Sex Differences in Breakthrough Stroke Outcomes Despite Oral Anticoagulation for Atrial Fibrillation
• Asundexian for Secondary Prevention After Ischemic Stroke or TIA
• Marstacimab Prophylaxis in Hemophilia A/B with Inhibitors: A New Purpose
• FDA Approves First-in-Class Weekly Anifrolumab Autoinjector for Systemic Lupus Erythematosus 
• Cemdisiran in Generalized Myasthenia Gravis
• Medicare’s Impact on Early Sepsis Management and Discharge to Home
• Maralixibat Shows Broader Therapeutic Benefit for Children with Alagille Syndrome 
• Reaching the Littlest …

Raising The Barb: Evaluation Of Phenobarbital Use For Alcohol Withdrawal In Patients On General Medicine Floors, Seth Arakawa, Jason Frederick, Anthony Le

Books, Presentations, Posters, Etc.

Abstract: Alcohol withdrawal syndrome (AWS) can present as a spectrum of symptoms such as a mild headache, gastrointestinal issues, and diaphoresis. However, if not treated properly, it can progress to severe hallucinations, seizures, or delirium tremens. Current guidelines from the American Society of Addiction Medicine (ASAM) recommend benzodiazepines as first line agents for alcohol withdrawal with phenobarbital recommended as an adjunct agent or replacement to benzodiazepines by providers who are familiar with its use. Although most evidence supporting phenobarbital in AWS comes from critical care settings, emerging data suggest it may also be safe and effective in general ward patients. …

Pacific Rxtracts - April 2026, Pacific Rxtracts

Pacific RxTracts

Articles:

• LAMA‑LABA Inhalers in COPD
• Another Potential Indication for Dupilumab: Chronic Spontaneous Urticaria
• Clinical Pharmacist‑Led Tobacco Treatment and Contingency Management in Patients With HIV
• FDA Approves First TYK2 Inhibitor for Adults With Active Psoriatic Arthritis
• Oral PCSK9 Inhibition with Enlicitide: A New Frontier in Lipid‑Lowering Therapy
• Lerodalcibep‑liga, Novel PCSK9 Inhibitor for the Management of Hypercholesterolemia
• Pharmaceutical Grade Cannabidiol for Myocardial Recovery in Acute Myocarditis
• Berberine Shows Limited Impact on Visceral and Liver Fat in MASLD Trial
• Comparative Outcomes of Orforglipron and Oral Semaglutide in Adults with Type 2 Diabetes
• Battling Pediatric Episodic Migraines – FDA Expands Approval of Fremanezumab
• Navepegritide …

Sharksrx Newsletter Spring 2026, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Pacific Rxtracts - March 2026, Pacific Rxtracts

Pacific RxTracts

Articles:

• FDA Approves Zycubo as First Treatment for Menkes Disease
• A Step Toward New Lung Treatment - FDA Expands Nerandomilast Approval
• Olezarsen for Severe Hypertriglyceridemia and Pancreatitis Prevention
• Increasing Accessibility of Treatment for Hepatitis C Through Telemedicine
• Efficacy of a Shortened Romosozumab Therapy followed by Denosumab in Postmenopausal Osteoporosis
• Renal Outcomes of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in T2D
• Plozasiran, A Novel Therapy for Familial Chylomicronemia Syndrome
• Incretin Agonists and Reduced CPAP Use in Obesity-Related Obstructive Sleep Apnea
• Icotrokinra: A Novel Oral Therapy for Plaque Psoriasis
• Omega-3 Fatty Acids in Pediatric Major Depressive Disorder: Limited Benefit as Adjunctive Therapy …

Pacific Rxtracts - February 2026, Pacific Rxtracts

Pacific RxTracts

Articles:

• Reducing Proteinuria – FDA Accelerates Approval of Sibeprenlimab
• FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
• New First-Line Digital Treatment for Generalized Anxiety Disorder
• Ammoxetine: A Potential New Antidepressant For Major Depressive
• Extended-Release Buprenorphine Dosing in Individuals With High-Risk Opioid Use
• Managing Acute Agitation Without Injections: Oral Medications in the ED
• Prescription Stimulant Continuation in Pregnancy and Birth Outcomes
• Zoliflodacin - A New Treatment For Gonorrhea
• Intranasal Dexmedetomidine for Postoperative Sleep Quality After Gynecologic Laparoscopy
• FDA Approves Depemokimab, the First Twice-Yearly Biologic for Severe Eosinophilic Asthma Cancer Care
• Engineering Allogeneic CD7-Targeted CAR-T Cells Through Targeted Base …

Reducing Healthcare Spending With Pharmacist Driven Icg Allocation, Rachel W. Wong, Calvin Le, Vanessa Sifuentes, Faith Rutherford, Grace Desrochers, Zuhair Ali, Mike K. Liang

Gulf Coast Division GME Research Day 2026

No abstract provided.

Beyond Clinical Outcomes: The Operational And Financial Benefits Of Insulin Lispro In Hyperkalemia Protocols, Cassandra Van Horn, Kevin Welch, Justin Solomon

MidAmerica Division GME Healthcare Symposium 2026

No abstract provided.

Effect Of Lifestyle And Medication Adherence On Type 2 Diabetes Management In Hospital Patients, Mohammed Irfan Lari

Covenant Nurses Week 2026

No abstract provided.

Impact Of Pharmacist Intervention And Cardiac Rehab In Post-Acute Myocardial Infarction Patients On 90-Day Readmission Rates, Paige Hall, Jennifer Wong, Tricia Walsh

MidAmerica Division GME Healthcare Symposium 2026

No abstract provided.

Association Of Acetaminophen/Butalbital/Caffeine Doses And Incidence Of Cerebral Vasospasm, Emma Cloud, Mallory Stringer, Eric Shaw

South Atlantic Division GME Research Days 2026

No abstract provided.

Incidence Of Sodium Overcorrection With Acute Tolvaptan Use, Emma Cloud, Alisha B. Terry

South Atlantic Division GME Research Days 2026

No abstract provided.

Burnout Amongst Pharmacy Preceptors Across The United States, Rachel Denison, Audrey Johnson, Danielle Croegaert, Eric Shaw

South Atlantic Division GME Research Days 2026

No abstract provided.

Evaluation Of Levetiracetam Use In Aneurysmal Subarachnoid Hemorrhage And Spontaneous Intracranial Hemorrhage For Seizure Prophylaxis, Taylor Dodd, Mallory Stringer, Eric Shaw

South Atlantic Division GME Research Days 2026

No abstract provided.